tiprankstipranks
Trending News
More News >
Matinas BioPharma Holdings (DE:6LJ0)
:6LJ0
Germany Market

Matinas BioPharma (6LJ0) Ownership - Who Owns Matinas BioPharma?

Compare
0 Followers

Matinas BioPharma (6LJ0) Ownership Overview

16.51%1.96%1.24%1.15%79.14%
16.51%
Insiders
1.96%
Mutual Funds
1.24% Other Institutional Investors
1.15% ETFs
79.14% Public Companies and Individual Investors
The ownership structure of Matinas BioPharma (DE:6LJ0) stock is a mix of institutional, retail, and individual investors. Approximately 4.34% of the company’s stock is owned by Institutional Investors, 16.51% is owned by Insiders, and 79.14% is owned by Public Companies and Individual Investors.
The ownership structure of Matinas BioPharma (DE:6LJ0) stock is a mix of institutional, retail, and individual investors. Approximately 3.19% of the company’s stock is owned by Institutional Investors, 16.51% is owned by Insiders, and 1.15% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
840,011Insider16.51%50,401
128,956Institution2.54%7,737
58,387Institution1.15%3,503
58,387Institution1.15%3,503
41,092Institution0.81%2,466

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
58,387Institution1.15%3,503
41,092Institution0.81%2,466

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Matinas BioPharma Holdings (DE:6LJ0)?
According to the latest TipRanks data, approximately 1.24% of the company's stock is held by institutional investors, 16.51% is held by insiders, and 79.14% is held by retail investors.
    What percentage of Matinas BioPharma Holdings (DE:6LJ0) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.24% of Matinas BioPharma Holdings (DE:6LJ0) stock is held by institutional investors.
      What percentage of Matinas BioPharma Holdings (DE:6LJ0) stock is held by retail investors?
      According to the latest TipRanks data, approximately 79.14% of Matinas BioPharma Holdings (DE:6LJ0) stock is held by retail investors.
        Who owns the most shares of Matinas BioPharma Holdings (DE:6LJ0)?
        Jerome D Jabbour owns the most shares of Matinas BioPharma Holdings (DE:6LJ0).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis